DHR Health Institute for Research and Development Recognized as a “Top Performing Site” Once Again

Translate to Spanish or other 102 languages!

THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
- Advertisement -

EDINBURG, Texas – The DHR Health Institute for Research and Development is delighted to announce that it has once again been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This marks the third consecutive time the Institute has received this prestigious distinction.

This recognition highlights the ongoing excellence and impact of the Research Institute as it continues to advance cancer research and improve patient outcomes.

“We are deeply honored and this recognition would not be possible without the assistance of the DHR Health Oncology Institute and the leadership of Dr. Jose Cruz,” said Dr. Scott Lillibridge, executive vice president for the DHR Health Institute for Research and Development.

- Advertisement -

SWOG is a global cancer research community supported by the National Cancer Institute (NCI), and recognition as a “Top Performing Site” signifies exceptional performance in clinical trial enrollment, data quality, and patient care standards.

The DHR Health Institute for Research and Development remains committed to innovation and delivering high-quality research opportunities to all residents of the Rio Grande Valley. They are located at 5323 S. McColl Road in Edinburg. For more information about clinical trials in the areas of liver, obesity, cancer, neurology, oncology and urology, call the Institute at (956) 362-2390.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Heart Valve Designed to Grow with Children

The U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.

STHS Clinics Surgeon Dr. Miguel Rodriguez Earns Prestigious National Recognition

Miguel Rodriguez, DO, FACS, a general, robotic and bariatric surgeon with STHS Clinics, has been inducted as a Fellow of the American College of Surgeons (ACS), earning the prestigious FACS designation.

AACT Now Launches Rally the Vote Across Rio Grande Valley

The Advocacy Alliance Center of Texas, or AACT Now, launched its Rally the Vote initiative Thursday, bringing together community organizations and regional leaders to expand access to nonpartisan voter information across the Rio Grande Valley.

Healthcare Alliance Recognizes Texas Oncology Investment in Valley Cancer Care

Maritza Gonzalez, founder and director of the Texas Healthcare Alliance Chamber of Commerce, recognized Texas Oncology’s continued investment in Rio Grande Valley cancer care during the Sept. 29 grand opening of the Texas Oncology McAllen West clinic.
- Advertisement -